Home
Hannah Valantine, Director: BridgeBio Pharma BBIO Sell · Filed 25/11/14
Trade details
- Type
- Insider sale
- Amount
- $1,683,727.88
- Shares · price
- 25,484 sh · $66.07 a share
- Held after
- 7,465 sh
- Person
- Hannah ValantineDirector
- Trade date
- 25/11/12
- Filed
- 25/11/14
- Days to filing
- 2 days
Sold 77.3% of holdings
- Share of holding sold
- 77.3%
BridgeBio Pharma trades, last 26 weeks
What else happened in BridgeBio Pharma around then
Filed or reported within 30 days of the trade day · 25/10/13~25/12/12Hannah Valantine's recent trades
- Hannah Valantine
Planned sale10b5-1 planCareDx
Planned sale10b5-1 planCareDx
CDNA
$856.2K
28,779 sh
$856.2K
Filed 07/16
Traded 07/16
- Hannah Valantine
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 planBridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/24
Traded 06/22
- Hannah Valantine
Sell10b5-1 planBridgeBio Pharma
Sell10b5-1 planBridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/24
Traded 06/23
- Hannah Valantine
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 planBridgeBio Pharma
BBIO
$150.6K
2,196 sh
$150.6K
Filed 06/23
Traded 06/23
- Hannah Valantine
Planned sale10b5-1 planBridgeBio Pharma
Planned sale10b5-1 planBridgeBio Pharma
BBIO
$190.9K
2,808 sh
$190.9K
Filed 06/22
Traded 06/22
